The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1973, 111: 1314-1325.
Copyright © 1973 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rubin, A. S.
Right arrow Articles by Coons, A. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rubin, A. S.
Right arrow Articles by Coons, A. H.

Specific Heterologous Enhancement of Immune Responses

V. Isolation of a Soluble Enhancing Factor from Supernatants of Specifically Stimulated and Allogeneically Induced Lymphoid Cells1

Arnold S. Rubin, A. Bruce MacDonald and Albert H. Coons2

From the Department of Pathology, Harvard Medical School, and the Department of Microbiology, Harvard University School of Public Health, Boston, Massachusetts 02115

Abstract

In cultures of thymocytes or spleen cells from tetanus toxoid-primed mice, the addition of 1 ng of toxoid generated the release of a soluble factor which was capable of nonspecifically enhancing the in vitro immune response of normal mouse spleen cells against sheep erythrocytes. When active supernatants were fractionated by gel filtration on Sephadex G-150 and Bio-Gel P-150, the active material eluted with molecules of approximately 75,000 m.w. Column fractions from similarly-treated supernatants from cultures of normal thymocytes or spleen cells, maintained with or without tetanus toxoid, were inactive. The enhancing activity recovered from the column fractions was degraded by treatment with the enzyme protease. A factor present in the supernatant fluid of cultures containing equal numbers of histoincompatible (allogeneic) spleen cells had similar properties. The enhancing factor was further purified by a combination of ammonium sulfate fractionation, Sephadex gel filtration, and polyacrylamide gel electrophoresis.

Footnotes

1 This work was supported by National Institutes of Health Grants AI 05691 and AI 00221.

2 Dr. Coons is a Career Investigator of the American Heart Association.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1973 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1973 by The American Association of Immunologists, Inc. All rights reserved.